Program

Day One

Friday, March 6th 2026

Day Two

Saturday, March 7th 2026

07:30 am Registration & Breakfast

08:30 am Inaugural Programme

Session I - Aplastic Anemia

Chair Person : Dr. Mammen Chandy and Dr. Srikanth Muralikrishnan

09:00 am What is new in the Immune Pathogenesis of Aplastic Anemia

shreyans
King's College Hospital NHS Trust, London

09:30 am IBMDX study – Prevalence of IBMFS in Australia

Royal Melbourne Hospital, Melbourne

10:00 am The Stem Cell niche in Aplastic Anemia

King George's Medical University, UP, Lucknow

10:30 am Coffee break

Session II - Lab Session I - Biology, Gene editing and diagnosis

Chair Person : Dr. Deepak Kumar Mishra and Dr. Poonkuzhali B

11:00 am Global DNA Methylation signature patterns in Fanconi Anemia: Can they predict cancer development?

ICMR-National Institute of Immunohaematology, Mumbai

11:25 am Whole genomic transcriptomic sequencing [WGTS]

Royal Melbourne Hospital, Melbourne

11:50 am High resolution Genomic Landscape of Aplastic Anemia: Insights into mechanisms of immune escape

St. Jude Children's Research Hospital, Memphis, USA.

12:15 pm Are we ready for WGS in the routine Genetic workup of rare diseases?

Vinod Scaria
CDFD, New Delhi

12:40 pm Lunch and poster session

Session III - Aplastic Anemia in children

Chair Person : Dr. Sudha Sethy and Dr. Ramaswamy

02:00 pm Congenital Dyserythropoietic Anemia: Molecular diagnosis and diagnostic approach in India

ICMR-National Institute of Immunohaematology, Mumbai

02:25 pm Haplo-Identical transplants for Fanconi Anemia

Stanford University, Stanford

02:50 pm Lentiviral Gene therapy

Shaji Velayudhan
Christian Medical College, Vellore, India

03:15 pm Challenges with managing Aplastic Anemia in children in India

Madras Medical College, Chennai

03:40 pm Tea Break

04:00 pm Alternate donor transplants in Aplastic Anemia (Virtual)

Carlo Dufour
Gaslini Hospital, Genoa

04:25 pm Stem cell transplantation in children with Aplastic Anemia

Apollo Hospital, Chennai

04:50 pm Monitoring patients following SCT in cancer predisposition syndromes (Virtual)

neelam-new
National Cancer Institute, Rockville, USA.

Session IV – Aplastic Anemia in India

Chair Person : Dr. Radhika K

05:20 pm How can we improve access to standard therapy for AA in India

prantar-chakrabarti
Sugah Healthcorp, Chennai

05:45 pm Panel discussion on managing AA in India

Session V – Long term complications

Chair Person : Dr. Biju George and Dr. Neeraj Sidharthan

06:25 pm Role of TPO agonists in Aplastic Anemia (Virtual)

Hospital A Beneficência Portuguesa, São Paulo, Brazil

06:55 pm Pathophysiology and long term complications of PNH (Virtual)

austin
King's College Hospital, London, UK.

07:30 pm Dinner

07:00 am Registration + Breakfast

Session VI - Myelodysplastic Syndromes/PNH

Chair Person : Dr. Sharon Lionel and Dr. Aruna Rajendran

08:00 am MDS – Is morphology still useful in diagnosis

Mahatma Gandhi Medical College and Research Institute, Pondicherry

08:25 am Paediatric MDS: Role of Germline Predisposition

St. Jude Children's Research Hospital, Memphis, USA.

08:55 am Low risk MDS – How do we manage it

shreyans
King's College Hospital NHS Trust, London

09:25 am Managing high risk MDS in India

Believer’s Hospital, Thiruvalla

09:55 am Can we improve on transplant outcomes in MDS

Christian Medical College, Vellore

10:20 am Coffee Break

Session VII - Aplastic anemia - Indian perspective

Chair Person : Dr. Chandrakala S and Dr. Uday Kulkarni

10:50 am Identifying IBMFS in India

PGIMER, Chandigarh

11:10 am Genotype-Phenotype Heterogeneity in Fanconi Anemia

Christian Medical College, Vellore

11:30 am Managing older patients with Aplastic Anemia with ATG

Christian Medical College, Vellore

11:50 am Utility of oral drugs in the management of Aplastic Anemia

PGIMER, Chandigarh

12:10 pm Impact of pre-transplant infections on transplant outcomes in AA

CMC Vellore

12:30 pm Update on the Aplastic Anemia Registry

Biju-George
Christian Medical College, Vellore, India

12:50 pm Questions and Answers

01:05 pm Lunch

Session VIII - Aplastic anemia - Session II

Chair Person : Dr. Aby Abraham and Dr. Ajay Sharma

02:00 pm Antibody based conditioning for Fanconi Anemia

Stanford University, Stanford

02:30 pm Managing AA – The CMC Vellore Experience

Biju-George
Christian Medical College, Vellore, India

03:00 pm Where do I see the management of AA going in 2030 – A Futuristic Outlook (Virtual)

Hospital A Beneficência Portuguesa, São Paulo, Brazil

03:30 pm Closing ceremony followed by tea